Investors Watch List: Peregrine Semiconductor Corporation (NASDAQ:PSMI), Discovery Laboratories Inc. (NASDAQ:DSCO), Data I/O Corp. (NASDAQ:DAIO), Geeknet, Inc. (NASDAQ:GKNT), Adobe Systems Inc. (NASDAQ:ADBE)
On 28 JULY Peregrine Semiconductor Corporation (NASDAQ:PSMI) last released its earnings data on Monday. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by $0.01. The company had revenue of $47.10 million for the quarter, compared to the consensus estimate of $44.13 million. During the same quarter in the previous year, the company posted $0.03 earnings per … Continue reading Investors Watch List: Peregrine Semiconductor Corporation (NASDAQ:PSMI), Discovery Laboratories Inc. (NASDAQ:DSCO), Data I/O Corp. (NASDAQ:DAIO), Geeknet, Inc. (NASDAQ:GKNT), Adobe Systems Inc. (NASDAQ:ADBE)
“The Goldfinch” Helps Hachette Defy Amazon.com, Inc. (NASDAQ:AMZN)’s Attack
With no end in sight for Hachette’s long drawn out pricing battle with Amazon.com, Inc. (NASDAQ:AMZN), Donna Tartt’s ‘The Goldfinch’ might be the silver lining in dark cloud looming over the publisher. Trouble has been brewing in the book world since this May as Amazon and Hachette could not agree how to split the revenues from sales of ebooks. Though many new titles from Hachette … Continue reading “The Goldfinch” Helps Hachette Defy Amazon.com, Inc. (NASDAQ:AMZN)’s Attack
Morning Buzz: PharMerica (NYSE:PMC), Array BioPharma (NASDAQ:ARRY), Mobile Mini (NASDAQ:MINI), Genocea Biosciences, Inc. (NASDAQ:GNCA), Health Care REIT, Inc. (NYSE:HCN)
PharMerica Corporation (NYSE:PMC) reported its financial results for the second quarter and six months ended June 30, 2014. Revenues for the second quarter of 2014 were $448.6 million compared with $430.8 million for the second quarter of 2013. The increase in revenue was primarily the result of the fourth quarter 2013 acquisitions and branded drug price inflation, and was partially offset by previously disclosed bed … Continue reading Morning Buzz: PharMerica (NYSE:PMC), Array BioPharma (NASDAQ:ARRY), Mobile Mini (NASDAQ:MINI), Genocea Biosciences, Inc. (NASDAQ:GNCA), Health Care REIT, Inc. (NYSE:HCN)
5 Stocks Under Wall Street’s Radar: CBD Energy (NASDAQ:CBDE), Evoke Pharma (NASDAQ:EVOK), ULTA Salon, Cosmetics & Fragrance (NASDAQ:ULTA), Medgenics, Inc. (NYSEMKT:MDGN), Aluminum (NYSE:ACH)
CBD Energy Limited (NASDAQ:CBDE), a diversified clean energy company and leading global provider of solar systems, has, through its Australian Energy Efficiency subsidiary, Parmac, been awarded installation and maintenance contracts in Melbourne, Australia. The total estimated value of the contracts is approximately US$1.7 million. The projects are expected to be commissioned in September and to be completed in December, 2014.CBD Energy Limited (NASDAQ:CBDE) belongs to … Continue reading 5 Stocks Under Wall Street’s Radar: CBD Energy (NASDAQ:CBDE), Evoke Pharma (NASDAQ:EVOK), ULTA Salon, Cosmetics & Fragrance (NASDAQ:ULTA), Medgenics, Inc. (NYSEMKT:MDGN), Aluminum (NYSE:ACH)
Momentum Stocks: Lattice Semiconductor (NASDAQ:LSCC), CVS Caremark (NYSE:CVS), Silicom (NASDAQ:SILC), Galena Biopharma, Inc. (NASDAQ:GALE), Alexander & Baldwin, Inc. (NYSE:ALEX)
Lattice Semiconductor Corporation (NASDAQ:LSCC) today announced that it is scheduled to present at Jefferies Semiconductors, Hardware & Communications Infrastructure Summit taking place on Wednesday, August 27th at the Ritz Carlton in Chicago. Lattice Semiconductor Corporation (NASDAQ:LSCC) belongs to Technology sector. Its net profit margin is 10.50% and weekly performance is 4.81%. On last trading day company shares ended up $7.53. Lattice Semiconductor Corporation (NASDAQ:LSCC) distance … Continue reading Momentum Stocks: Lattice Semiconductor (NASDAQ:LSCC), CVS Caremark (NYSE:CVS), Silicom (NASDAQ:SILC), Galena Biopharma, Inc. (NASDAQ:GALE), Alexander & Baldwin, Inc. (NYSE:ALEX)
Biotech Stocks Highlights: A look at Last Week’s Performance
With second quarter earnings season coming to an end, focus in the biotech sector is back on pipeline and regulatory updates. Last week’s highlights included Achillion Pharmaceuticals, Inc.’s (ACHN) impressive interim data on its experimental hepatitis C virus (HCV) treatment, Gilead Sciences’ (GILD – Analyst Report) legal victory and Amgen’s (AMGN – Analyst Report) hit and miss on the clinical front. Achillion, which focuses on … Continue reading Biotech Stocks Highlights: A look at Last Week’s Performance
